{"entity":{"type":"insider","cik":"0001260573","url":"/insider/0001260573","json_url":"/insider/0001260573.json","name":"KARSEN PERRY A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":11,"first":"2013-08-02","last":"2020-12-18","span_basis":"filed_date"},"name_variants":[{"name":"KARSEN PERRY A","source":"filing","n_filings":11,"first_seen":"2013-08-02","last_seen":"2020-12-18"}],"transactions":[{"id":2120781,"accession":"0001209191-20-064425","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-064425","line_url":"/filing/0001209191-20-064425","is_derivative":false,"issuer_cik":"0001260573","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001260573","owner_cik":"0001260573","owner_name":"KARSEN PERRY A","owner_display_name":"KARSEN PERRY A","owner_url":"/insider/0001260573","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88764.0,"shares_display":"88,764","price_per_share":53.55414289576856,"price_display":"53.55","price_state":"stated","total_value":4753679.94,"total_display":"4,753,679.94","total_whole":"4,753,680","shares_owned_after":26336.0,"shares_owned_after_display":"26,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-17","filed_date":"2020-12-18","scope":"insider","n_lines":3},{"id":5074394,"accession":"0001140361-17-024400","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-024400","line_url":"/filing/0001140361-17-024400#line-1","is_derivative":false,"issuer_cik":"0001260573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001260573","owner_cik":"0001260573","owner_name":"KARSEN PERRY A","owner_display_name":"KARSEN PERRY A","owner_url":"/insider/0001260573","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.4588,"price_display":"3.46","price_state":"stated","total_value":34588.0,"total_display":"34,588.00","total_whole":"34,588","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-05","filed_date":"2017-06-07","scope":"insider"},{"id":4485426,"accession":"0001104659-17-006179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-006179","line_url":"/filing/0001104659-17-006179#line-1","is_derivative":false,"issuer_cik":"0001260573","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001260573","owner_cik":"0001260573","owner_name":"KARSEN PERRY A","owner_display_name":"KARSEN PERRY A","owner_url":"/insider/0001260573","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","total_whole":"80,000","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-01","filed_date":"2017-02-02","scope":"insider"},{"id":8899856,"accession":"0001209191-15-013666","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-013666","line_url":"/filing/0001209191-15-013666#line-4","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001260573","owner_name":"KARSEN PERRY A","owner_display_name":"KARSEN PERRY A","owner_url":"/insider/0001260573","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"see remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27896.0,"shares_display":"27,896","price_per_share":120.115,"price_display":"120.12","price_state":"stated","total_value":3350728.04,"total_display":"3,350,728.04","total_whole":"3,350,728","shares_owned_after":70117.0,"shares_owned_after_display":"70,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-11","filed_date":"2015-02-13","scope":"insider"},{"id":8824302,"accession":"0001209191-15-000187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-000187","line_url":"/filing/0001209191-15-000187#line-2","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001260573","owner_name":"KARSEN PERRY A","owner_display_name":"KARSEN PERRY A","owner_url":"/insider/0001260573","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"see remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19273.0,"shares_display":"19,273","price_per_share":113.37,"price_display":"113.37","price_state":"stated","total_value":2184980.01,"total_display":"2,184,980.01","total_whole":"2,184,980","shares_owned_after":55471.0,"shares_owned_after_display":"55,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-30","filed_date":"2015-01-02","scope":"insider"},{"id":6532119,"accession":"0001209191-14-068839","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-068839","line_url":"/filing/0001209191-14-068839#line-4","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001260573","owner_name":"KARSEN PERRY A","owner_display_name":"KARSEN PERRY A","owner_url":"/insider/0001260573","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"see remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39420.0,"shares_display":"39,420","price_per_share":107.23,"price_display":"107.23","price_state":"stated","total_value":4227006.6,"total_display":"4,227,006.60","total_whole":"4,227,007","shares_owned_after":51410.0,"shares_owned_after_display":"51,410","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-14","scope":"insider"},{"id":6530487,"accession":"0001209191-14-050578","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-050578","line_url":"/filing/0001209191-14-050578#line-2","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001260573","owner_name":"KARSEN PERRY A","owner_display_name":"KARSEN PERRY A","owner_url":"/insider/0001260573","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"see remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39104.0,"shares_display":"39,104","price_per_share":87.5469,"price_display":"87.55","price_state":"stated","total_value":3423433.9776,"total_display":"3,423,433.98","total_whole":"3,423,434","shares_owned_after":58756.0,"shares_owned_after_display":"58,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-04","filed_date":"2014-08-05","scope":"insider"},{"id":6614431,"accession":"0001209191-14-031265","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-031265","line_url":"/filing/0001209191-14-031265#line-2","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001260573","owner_name":"KARSEN PERRY A","owner_display_name":"KARSEN PERRY A","owner_url":"/insider/0001260573","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"see remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11922.0,"shares_display":"11,922","price_per_share":146.78,"price_display":"146.78","price_state":"stated","total_value":1749911.16,"total_display":"1,749,911.16","total_whole":"1,749,911","shares_owned_after":25705.0,"shares_owned_after_display":"25,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-01","filed_date":"2014-05-05","scope":"insider"},{"id":7011523,"accession":"0001209191-14-017340","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-017340","line_url":"/filing/0001209191-14-017340#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001260573","owner_name":"KARSEN PERRY A","owner_display_name":"KARSEN PERRY A","owner_url":"/insider/0001260573","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"see remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2408.0,"shares_display":"2,408","price_per_share":159.05,"price_display":"159.05","price_state":"stated","total_value":382992.4,"total_display":"382,992.40","total_whole":"382,992","shares_owned_after":25960.0,"shares_owned_after_display":"25,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-03","filed_date":"2014-03-05","scope":"insider"},{"id":4269135,"accession":"0001209191-13-039044","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-13-039044","line_url":"/filing/0001209191-13-039044#line-5","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001260573","owner_name":"KARSEN PERRY A","owner_display_name":"KARSEN PERRY A","owner_url":"/insider/0001260573","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"see remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93008.0,"shares_display":"93,008","price_per_share":146.5,"price_display":"146.50","price_state":"stated","total_value":13625672.0,"total_display":"13,625,672.00","total_whole":"13,625,672","shares_owned_after":12494.0,"shares_owned_after_display":"12,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-02","filed_date":"2013-08-02","scope":"insider"},{"id":8670971,"accession":"0001209191-15-043351","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-043351","line_url":"/filing/0001209191-15-043351#line-1","is_derivative":false,"issuer_cik":"0000816284","issuer_name":"CELGENE CORP /DE/","issuer_ticker":"CELG","issuer_name_source":null,"issuer_url":"/issuer/0000816284","owner_cik":"0001260573","owner_name":"KARSEN PERRY A","owner_display_name":"KARSEN PERRY A","owner_url":"/insider/0001260573","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"see remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47173.0,"shares_display":"47,173","price_per_share":115.0,"price_display":"115.00","price_state":"stated","total_value":5424895.0,"total_display":"5,424,895.00","total_whole":"5,424,895","shares_owned_after":62820.0,"shares_owned_after_display":"62,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-13","filed_date":"2015-05-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001652130","name":"Intellia Therapeutics, Inc.","url":"/issuer/0001652130","role":"Director","n_filings":1,"first_seen":"2020-12-18","last_seen":"2020-12-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001302573","name":"OncoMed Pharmaceuticals Inc","url":"/issuer/0001302573","role":"Director","n_filings":1,"first_seen":"2017-06-07","last_seen":"2017-06-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001640455","name":"Jounce Therapeutics, Inc.","url":"/issuer/0001640455","role":"Director","n_filings":1,"first_seen":"2017-02-02","last_seen":"2017-02-02"},{"type":"issuer","type_label":"ISSUER","cik":"0000816284","name":"CELGENE CORP /DE/","url":"/issuer/0000816284","role":"Officer","n_filings":8,"first_seen":"2013-08-02","last_seen":"2015-05-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001260573","retrieved_at":"2026-08-23T16:37:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}